The Gross Margin of DaShenLin Pharmaceutical Group Co Ltd (603233.SS) is 35.61%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 35.61% |
| 2022-12-31 | 37.76% |
| 2021-12-31 | 38.03% |
| 2020-12-31 | 38.33% |
| 2019-12-31 | 39.40% |
| 2018-12-31 | 41.57% |
| 2017-12-31 | 40.13% |
| 2016-12-31 | 40.15% |
| 2015-12-31 | 40.85% |
| 2014-12-31 | 40.15% |